OBJECTIVE: To evaluate the biological effects of newly developed β-tricalcium phosphate (β-TCP) to improve lateral bone augmentation. MATERIAL AND METHODS: Test samples (rod-shaped [RS]-blocks) were prepared through hydrothermal processing α-TCPs. As controls, commercially available β-TCPs (C-blocks; Osferion) were used. The blocks were placed onto the rabbit mandibles (n=5/group, mean: 4 kg). Samples were retrieved after 6, 12 and 24 weeks. Thereafter, the sections were evaluated for histological and histomorphometric analyses. The parameters set were: BV/TV (%): [(area of newly formed bone; area-NFB)/(whole measured area; WA)] × 100, BV+Imp.V/TV (%): [(area-NFB+area of remaining β-TCP block)/WA] × 100, N.Oc/I.Pm: (osteoclast number)/(entire β-TCP block perimeter; 100 mm). RESULTS: BV/TV of the C-blocks (10.71 ± 3.39%) was significantly higher than the RS-blocks (3.5 ± 3.52%, P<0.05) at 6 weeks. At 24 weeks, the RS-blocks (23.66 ± 2.7%) showed significantly higher values than the C-blocks (13.23 ± 2.65%, P<0.001). The BV+Imp.V/TV of the RS-blocks was significantly higher than that of the C-block group (29.61 ± 5.84% and 19.13 ± 3.14%), maintaining high values between 6 and 24 weeks (44.16 ± 5.19% and 50.88 ± 4%, P<0.001). The N.Oc/I.Pm values were significantly greater in the RS-block group than in the C-block group throughout the observation period (P<0.05). CONCLUSIONS: The newly developed β-TCP blocks presented subsequent replacement by newly formed bone, in conjunction with maintaining the external morphology.
No takes yet. Share an insight, caveat, or question.
Ono et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: